MedTrace Logo

Biomarkers in Tissue Samples From Patients With Stage I or Stage III Endometrial Cancer

NCT01119573 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2010-06-22

No results posted yet for this study

Summary

RATIONALE: Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors identify and learn more about biomarkers related to cancer.

PURPOSE: This research study is studying at biomarkers in tissue samples from patients with stage I or stage III endometrial cancer.

Conditions

Interventions

GENETIC

RNA analysis

GENETIC

microarray analysis

GENETIC

reverse transcriptase-polymerase chain reaction

OTHER

laboratory biomarker analysis

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Gynecologic Oncology Group

    lead NETWORK

Principal Investigators

  • David S. Miller, MD · Simmons Cancer Center

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-05-31
Primary Completion
2010-06-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01119573 on ClinicalTrials.gov